Seasoned biologics drug researcher with twenty years of industry experience spanning discovery through IND submission.
Demonstrated success in building and leading high-performing teams within matrix organizations.
Proficient in strategic planning and the execution of both internal and external partnerships.
Extensive expertise in biology and biologics, complemented by strong communication abilities.
Driven to deliver meaningful patient outcomes with a sense of urgency, leveraging innovation and drug discovery to support the organization's vision and strategic objectives.
Professional Experience
Vice President, Protein Therapeutics Research, Gilead Sciences, Foster City, CA, 2022-present
Executive Director, Discovery Biologics, Merck Research Laboratories, Boston, MA, 2017-2022
Volwiler Research Fellow and Project Director (2015-2017), Associate Director II and Project Director (2014-2015), Global Biologics, AbbVie Bioresearch Center, Worcester, MA, 2014-2017
Associate Director I (2011-2014), Sr. Group Leader (2008-2011), Sr. Scientist III (2006-2008), Sr. Scientist II (2002-2006), Global Biologics, AbbVie Bioresearch Center, Worcester, MA, 2002-2014
Scientist II, Functional Genomics, Interleukin Genetics, Waltham, MA, 2002
Instructor in Medicine, Vascular Biology Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 2001-2002
Post-doc/Research Fellow, Cardiovascular Biology Laboratory, Harvard School of Public Health, and Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, 1998-2000
Education
Doctor of Science, Division of Biological Sciences, Harvard School of Public Health, Boston, MA, 1992-1998
PhD program in Cell Biology, New York University School of Medicine, New York, NY (Transferred to Harvard after the first year), 1991-1992
Bachelor of Science, Zoology, National Taiwan University, Taipei, Taiwan, 1985-1989
Professional Societies
Member, American Society for Biochemistry and Molecular Biology, 1996-Present
